wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47657450-0527D5EF-C95F-4C6F-893F-42946E5212A3
Q47657450-0527D5EF-C95F-4C6F-893F-42946E5212A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657450-0527D5EF-C95F-4C6F-893F-42946E5212A3
A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
P2860
Q47657450-0527D5EF-C95F-4C6F-893F-42946E5212A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657450-0527D5EF-C95F-4C6F-893F-42946E5212A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd98521f8b78ea86d4ff4e934de7081ed51898b1
P2860
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.